Making Great Strides in Cancer Treatment

Our scientists are advancing the development of immune-based therapies for cancer patients thanks to our donors and supporters. Learn more about their research and impact.

James P. Allison, Ph.D.
The University of Texas at MD Anderson Cancer Center
CRI Scientific Advisory Council director James Allison explains why "taking the brakes off" T cells is a good way to fight cancer.
Jeffrey Chou, M.D., Ph.D.
Fred Hutchinson Cancer Research Center
New studies from this CRI scientist may help to make colorectal cancer more vulnerable to attack by the immune system.
Ian H. Frazer, AC, FRS, FAA
The University of Queensland, Australia
The CRI Clinical Investigator is modest about his contribution to the development of the recently-announced breakthrough cervical cancer vaccine.
Jing-Ping Hsin, Ph.D.
Memorial Sloan Kettering Cancer Center
The CRI Young Philanthropist Fellow's research on gene expression in cancer can impact the way lymphoma is treated.
Carl H. June, M.D.
University of Pennsylvania
Pancreatic cancer patients will be enrolled in a clinical trial of a new immunotherapy that harnesses the immune system’s ability to fight pancreatic cancer.
Hyam I. Levitsky, M.D.
Johns Hopkins University
Dr. Levitsky is in a unique position to facilitate academic-industry partnerships that will advance the development of cancer immunotherapies.
Haihui Lu, Ph.D.
Whitehead Institute for Biomedical Research
As a postdoctoral fellow funded by CRI, Dr. Lu is forging new knowledge on how breast cancer tumors "hijack" macrophages to facilitate cancer metastasis and immune evasion.
Kunle Odunsi, M.D., Ph.D.
Roswell Park Cancer Institute
CRI physician-scientist Kunle Odunsi, M.D., Ph.D., is leading the way in cancer immunotherapy for ovarian cancer.
Oliver M. Pearce, Ph.D.
University of California, San Diego
A CRI postdoctoral fellow is researching the link between red meat, milk, and carcinomas.
Corrie Painter, Ph.D.
University of Massachusetts
Angiosarcoma patient and CRI postdoctoral fellow Dr. Corrie Painter is studying how immune cells in zebrafish can fight against hers and other cancers.
David A. Reardon, M.D.
Dana-Farber Cancer Institute
For glioblastoma, the most dangerous and aggressive form of brain cancer, fewer than 10 percent of patients survive more than 5 years. Dr. Reardon wants to change that.
Antoni Ribas, M.D., Ph.D.
University of California, Los Angeles
Dr. Ribas, of UCLA, discusses his latest immunotherapy clinical trials and how it'll transform cancer treatment.
Robert Schreiber, Ph.D.
Washington University School of Medicine
By redefining our understanding of the relationship between cancer and the immune system, Dr. Robert Schreiber has brought us closer to cures for cancer
Padmanee Sharma, M.D., Ph.D.
The University of Texas at MD Anderson Cancer Center
Dr. Sharma's translational research focuses on learning how to apply immune-based therapeutic strategies to manipulate components of the human immune system to lead to tumor regression.
Ralph Steinman, M.D.
The Rockefeller University
Dr. Steinman discusses his pioneering research on the role of dendritic cells in the immune system's response to cancer.
Jedd D. Wolchok, M.D., Ph.D.
Memorial Sloan Kettering Cancer Center
The leading immunotherapy expert knows better than almost anyone what clinical trials can do for patients.
Matthew Youngman, Ph.D.
Massachusetts Institute of Technology
A CRI postdoctoral fellow is exploring the link between aging and the immune system, and his work could lead to new immunotherapies that boost protection against cancer.
Let's spread the word about Immunotherapy! Click to share this page with your community.

*Immunotherapy results may vary from patient to patient.